By InvitationNot Applicable

Observation of Clozapine Treatment Safety in Bipolar Disorder.

Poland30 participantsStarted 2023-02-23

Plain-language summary

The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of treatment-resistant depressive episode in the course of bipolar disorder according to DSM-5. * Age from 18 to 65 years old. Exclusion Criteria: * Patients unable to give fully written informed consent * Patients unable to comply with the requirements

What they're measuring

Safety measures of clozapine treatment in patients with bipolar disorder.

Timeframe: 1 year

Trial details

NCT IDNCT06011460

SponsorMedical University of Gdansk

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Bipolar Disorder trials